Literature DB >> 18577512

p21 Ras/impedes mitogenic signal propagation regulates cytokine production and migration in CD4 T cells.

Jan Czyzyk1, Hui-Chen Chen, Kim Bottomly, Richard A Flavell.   

Abstract

The propensity of T cells to generate coordinated cytokine responses is critical for the host to develop resistance to pathogens while maintaining the state of immunotolerance to self-antigens. The exact mechanisms responsible for preventing the overproduction of proinflammatory cytokines including interferon (IFN)-gamma are not fully understood, however. In this study, we examined the role of a recently described Ras GTPase effector and repressor of the Raf/MEK/ERK cascade called impedes mitogenic signal propagation (Imp) in limiting the induction of T-cell cytokines. We found that stimulation of the T cell receptor complex leads to the rapid development of a physical association between Ras and Imp. Consistent with the hypothesis that Imp inhibits signal transduction, we also found that disengagement of this molecule by the Ras(V12G37) effector loop mutant or RNA interference markedly enhances the activation of the NFAT transcription factor and IFN-gamma secretion. A strong output of IFN-gamma is responsible for the distinct lymphocyte traffic pattern observed in vivo because the transgenic or retroviral expression of Ras(V12G37) caused T cells to accumulate preferentially in the lymph nodes and delayed their escape from the lymphoid tissue, respectively. Together, our results describe a hitherto unrecognized negative regulatory role for Imp in the production of IFN-gamma in T cells and point to Ras-Imp binding as an attractive target for therapeutic interventions in conditions involving the production of this inflammatory cytokine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577512      PMCID: PMC2516986          DOI: 10.1074/jbc.M804084200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Combinatorial effect of T-cell receptor ligation and CD45 isoform expression on the signaling contribution of the small GTPases Ras and Rap1.

Authors:  J Czyzyk; D Leitenberg; T Taylor; K Bottomly
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Ras signalling on the endoplasmic reticulum and the Golgi.

Authors:  Vi K Chiu; Trever Bivona; Angela Hach; J Bernard Sajous; Joseph Silletti; Heidi Wiener; Ronald L Johnson; Adrienne D Cox; Mark R Philips
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

3.  Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.

Authors:  Hiroshi Hanafusa; Satoru Torii; Takayuki Yasunaga; Eisuke Nishida
Journal:  Nat Cell Biol       Date:  2002-11       Impact factor: 28.824

4.  Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling.

Authors:  Y Yamanashi; T Tamura; T Kanamori; H Yamane; H Nariuchi; T Yamamoto; D Baltimore
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

5.  Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.

Authors:  AnhCo Nguyen; W Richard Burack; Jeffrey L Stock; Robert Kortum; Oleg V Chaika; Maryam Afkarian; William J Muller; Kenneth M Murphy; Deborah K Morrison; Robert E Lewis; John McNeish; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells.

Authors:  Patricia J Jorritsma; Jennifer L Brogdon; Kim Bottomly
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways.

Authors:  Irena Stefanová; Bernhard Hemmer; Marco Vergelli; Roland Martin; William E Biddison; Ronald N Germain
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

8.  Blocked Ras activation in anergic CD4+ T cells.

Authors:  P E Fields; T F Gajewski; F W Fitch
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

9.  p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl).

Authors:  A Di Cristofano; M Niki; M Zhao; F G Karnell; B Clarkson; W S Pear; L Van Aelst; P P Pandolfi
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

10.  Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation.

Authors:  M Zhao; A A Schmitz; Y Qin; A Di Cristofano; P P Pandolfi; L Van Aelst
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  9 in total

1.  BRAP Activates Inflammatory Cascades and Increases the Risk for Carotid Atherosclerosis.

Authors:  Yi-Chu Liao; Yung-Song Wang; Yuh-Cherng Guo; Kouichi Ozaki; Toshihiro Tanaka; Hsiu-Fen Lin; Ming-Hong Chang; Ku-Chung Chen; Ming-Lung Yu; Sheng-Hsiung Sheu; Suh-Hang Hank Juo
Journal:  Mol Med       Date:  2011-06-10       Impact factor: 6.354

2.  BRCA1-associated protein inhibits glioma cell proliferation and migration and glioma stem cell self-renewal via the TGF-β/PI3K/AKT/mTOR signalling pathway.

Authors:  Bo Wang; Chen Cao; Xi Liu; Xin He; Hao Zhuang; Dong Wang; Budong Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-27       Impact factor: 6.730

3.  An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease.

Authors:  Avijit Ray; Sreemanti Basu; Nichole M Miller; Andrew M Chan; Bonnie N Dittel
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

Review 4.  Signaling threshold regulation by the Ras effector IMP.

Authors:  Sharon A Matheny; Michael A White
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

5.  E3 ubiquitin ligase GRAIL controls primary T cell activation and oral tolerance.

Authors:  Martin A Kriegel; Chozhavendan Rathinam; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

6.  Brap2 regulates temporal control of NF-κB localization mediated by inflammatory response.

Authors:  Osamu Takashima; Fuminori Tsuruta; Yu Kigoshi; Shingo Nakamura; Jaehyun Kim; Megumi C Katoh; Tomomi Fukuda; Kenji Irie; Tomoki Chiba
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

7.  Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15.

Authors:  Sebastian D Hayes; Han Liu; Ewan MacDonald; Christopher M Sanderson; Judy M Coulson; Michael J Clague; Sylvie Urbé
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

8.  Central catalytic domain of BRAP (RNF52) recognizes the types of ubiquitin chains and utilizes oligo-ubiquitin for ubiquitylation.

Authors:  Shisako Shoji; Kazuharu Hanada; Noboru Ohsawa; Mikako Shirouzu
Journal:  Biochem J       Date:  2017-09-07       Impact factor: 3.857

Review 9.  Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity.

Authors:  Poojitha Sitaram; Bradley Uyemura; Subramaniam Malarkannan; Matthew J Riese
Journal:  Int J Mol Sci       Date:  2019-11-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.